Cover Image

Efficacy and Safety of Subcutaneous and Oral Semaglutide Administration in Patients With Type 2 Diabetes: A Meta-Analysis

Background: This meta-analysis aimed to combine the data available from clinical trials to assess the effects of subcutaneous and oral semaglutide administration on glycemic control, weight management, and safety outcomes in patients with type 2 diabetes (T2D).Methods: We systematically searched for...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ping Zhong (Author), Hai Zeng (Author), Miaochun Huang (Author), Guoxin He (Author), Zhixia Chen (Author)
Format:	Book
Published:	Frontiers Media S.A., 2021-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evolving role of semaglutide in NAFLD: in combination, weekly and oral administration
by: Evgenia Koureta, et al.
Published: (2024)

Evaluation and comparison of efficacy and safety of tirzepatide and semaglutide in patients with type 2 diabetes mellitus: A Bayesian network meta-analysis
by: Yanan Ding, et al.
Published: (2024)

Comparative analysis of semaglutide induced adverse reactions: Insights from FAERS database and social media reviews with a focus on oral vs subcutaneous administration
by: Jing Zhang, et al.
Published: (2024)

Efficacy and Safety of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Fang-Hong Shi, et al.
Published: (2018)

Enhanced Oral Efficacy of Semaglutide via an Ionic Nanocomplex with Organometallic Phyllosilicate in Type 2 Diabetic Rats
by: Gyu Lin Kim, et al.
Published: (2024)

Population pharmacokinetic of paracetamol and atorvastatin with co‐administration of semaglutide
by: Emilie K. Langeskov, et al.
Published: (2022)

Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide
by: Maria Elena Lunati, et al.
Published: (2024)

Cost-effectiveness analysis of once-daily oral semaglutide versus placebo and subcutaneous glucagon-like peptide-1 receptor agonists added to insulin in patients with type 2 diabetes in China
by: Zhen Feng, et al.
Published: (2023)

Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: A systematic review and meta-analysis of randomized controlled trials
by: Xueqin Gao, et al.
Published: (2022)

Semaglutide for the treatment of obesity
by: Rafał Oleszczuk, et al.
Published: (2022)

Clinical potential of treatment with semaglutide in type 2 diabetes patients
by: Michael E Røder
Published: (2019)

Efficacy and safety of subcutaneous immunotherapy in asthmatic children allergic to house dust mite: a meta-analysis and systematic review
by: Chen Zheng, et al.
Published: (2023)

Comparative analysis of physicochemical properties, bioequivalence, safety and tolerability of the first domestic semaglutide
by: A. S. Ametov, et al.
Published: (2024)

Semaglutide-associated bullous pemphigoid
by: Clayton P. Burruss, BS, et al.
Published: (2021)

Safety and Efficacy of Subcutaneous Daratumumab in Systemic AL Amyloidosis
by: Hughes MS, et al.
Published: (2023)

Profile of semaglutide in the management of type 2 diabetes: design, development, and place in therapy
by: Gomez-Peralta F, et al.
Published: (2019)

More Unnecessary Imaginary Worlds - Part 2: The ICER Evidence Report on Modeling Oral Semaglutide for Type 2 Diabetes
by: Paul Langley
Published: (2020)

Semaglutide in the Treatment of Diabetes and Associated Obesity
by: Rafal Makuch, et al.
Published: (2024)

Contractile Effects of Semaglutide in the Human Atrium
by: Joachim Neumann, et al.
Published: (2024)

Subcutaneous vaccine administration - an outmoded practice
by: Ian F. Cook
Published: (2021)

Clinical Pharmacokinetics of Semaglutide: A Systematic Review
by: Yang XD, et al.
Published: (2024)

Semaglutide: a game changer for metabolic diseases?
by: Agostino Milluzzo, et al.
Published: (2022)

Efficacy and safety of total glucosides of paeony in the treatment of 5 types of inflammatory arthritis: A systematic review and meta-analysis
by: Kailin Yang, et al.
Published: (2023)

SAFETY OF INTERFERON BETA 1A FOR A SUBCUTANEOUS ADMINISTRATION IN CHILDREN AND ADOLESCENTS WITH DISSEMINATED SCLEROSIS
by: O.V. Bykova, et al.
Published: (2008)

SAFETY OF INTERFERON BETA 1A FOR A SUBCUTANEOUS ADMINISTRATION IN CHILDREN AND ADOLESCENTS WITH DISSEMINATED SCLEROSIS
by: O.V. Bykova, et al.
Published: (2008)

Semaglutide versus Tirzepatide - comparison of both drugs in treatment of diabetes type 2 and weight reduction
by: Arkadiusz Staroń, et al.
Published: (2024)

Adverse events in different administration routes of semaglutide: a pharmacovigilance study based on the FDA adverse event reporting system
by: Kaibin Niu, et al.
Published: (2024)

Efficacy and safety of oral propranolol and topical timolol in the treatment of infantile hemangioma: a meta-analysis and systematic review
by: Xiaoye Huang, et al.
Published: (2024)

Efficacy and safety of tirzepatide in patients with type 2 diabetes: A systematic review and meta-analysis
by: Yan Tang, et al.
Published: (2022)

Subcutaneous palivizumab (Synagis®) administration in an infant with congenital type 2B von Willebrand disease
by: Karel Allegaert, et al.
Published: (2015)

Dose-dependent erythema nodosum after initiation of semaglutide
by: Jeffrey Sobieraj, MD, et al.
Published: (2024)

Cost consequence analysis of adding semaglutide to treatment regimen for patients with Type II diabetes in Saudi Arabia
by: Yazed AlRuthia, et al.
Published: (2024)

Exploring the Appropriate Price of Semaglutide for Type 2 Diabetes Patients Based on Cost-Utility Analysis in China
by: Shanshan Hu, et al.
Published: (2021)

Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
by: Tzaribachev N, et al.
Published: (2008)

Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset
by: Stefania Chiappini, et al.
Published: (2023)

Subcutaneous Oral Cysticercosis
by: Keyuri Patel, et al.
Published: (2011)

Subcutaneous methotrexate for symptomatic control of severe recalcitrant psoriasis: safety, efficacy, and patient acceptability
by: Manalo IF, et al.
Published: (2015)

Efficacy of subcutaneous interferon-beta in COVID-19: a meta-analysis and systematic review
by: Abuzar A. Asif, et al.
Published: (2021)

Nursing knowledge and practices regarding subcutaneous fluid administration
by: Nathália Silva Gomes, et al.

Payer Perspectives on Intravenous versus Subcutaneous Administration of Drugs
by: Epstein RS
Published: (2021)